S. Rosenberg (1998)
New opportunities for the development of cancer immunotherapies.The cancer journal from Scientific American, 4 Suppl 1
Dendritic Cell Vaccination of Stage IV Melanoma Patients in cancer immunotherapy
A. Enk, H. Jonuleit, J. Saloga, J. Knop (1997)
Dendritic cells as mediators of tumor‐induced tolerance in metastatic melanomaInternational Journal of Cancer, 73
F. Nestle, S. Alijagic, M. Gilliet, Yuansheng Sun, S. Grabbe, R. Dummer, G. Burg, D. Schadendorf (1998)
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 4
Koichi Shimizu, Ryan Fields, M. Giedlin, J. Mulé (1999)
Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines.Proceedings of the National Academy of Sciences of the United States of America, 96 5
(1998)
Novel methods to monitor antigen-specific cytotoxic T-cell responses D ow naded rom http://ess.org/jem /article-pdf/1969/514998/99-0918.pdf by R ocfeller U niersity user on
Romani (1996)
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicabilityJ. Immunol. Methods., 196
K. Steinbrink, H. Jonuleit, G. Müller, G. Schuler, J. Knop, A. Enk (1999)
Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells.Blood, 93 5
(1999)
Lippincott-Raven Publishers
P. Romero, P. Dunbar, D. Valmori, M. Pittet, G. Ogg, D. Rimoldi, Ji-Li Chen, D. Liénard, J. Cerottini, V. Cerundolo (1998)
Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T LymphocytesThe Journal of Experimental Medicine, 188
C. Caux, C. Massacrier, atrice Vanbervliet, B. Dubois, C. Kooten, I. Durand, J. Banchereau (1994)
Activation of human dendritic cells through CD40 cross-linkingThe Journal of Experimental Medicine, 180
Pardoll (1998)
Cancer vaccinesNat. Med., 4
B. Wong, R. Josien, Soo Lee, B. Sauter, Hong‐li Li, R. Steinman, Yongwon Choi (1997)
TRANCE (Tumor Necrosis Factor [TNF]-related Activation-induced Cytokine), a New TNF Family Member Predominantly Expressed in T cells, Is a Dendritic Cell–specific Survival FactorThe Journal of Experimental Medicine, 186
G. Schuler, N. Romani (1997)
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability.Advances in experimental medicine and biology, 417
M. Marchand, N. Baren, P. Weynants, V. Brichard, B. Dréno, M. Tessier, E. Rankin, G. Parmiani, F. Arienti, Y. Humblet, A. Bourlond, R. Vanwijck, D. Liénard, M. Beauduin, P. Dietrich, V. Russo, J. Kerger, G. Masucci, E. Jäger, J. Grève, J. Atzpodien, F. Brasseur, P. Coulie, P. Bruggen, T. Boon (1999)
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1International Journal of Cancer, 80
V. Lees, J. Briggs (1993)
Cutaneous melanoma.Journal of the American Academy of Dermatology, 29 2 Pt 1
O. Rajka (1963)
[TUMOR IMMUNOLOGY].Orvosi hetilap, 104
G. Murphy, B. Tjoa, H. Ragde, G. Kenny, A. Boynton (1996)
Phase I clinical trial: T‐cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA‐A0201‐specific peptides from prostate‐specific membrane antigenThe Prostate, 29
B. Thurner, Claudia Röder, D. Dieckmann, Marion Heuer, Monika Kruse, Anke Glaser, P. Keikavoussi, E. Kämpgen, Armin Bender, Gerold Schuler (1999)
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application.Journal of immunological methods, 223 1
Gerold Schuler, R. Steinman (1997)
Dendritic Cells as Adjuvants for Immune-mediated Resistance to TumorsThe Journal of Experimental Medicine, 186
S. Topalian, Monica Gonzales, M. Parkhurst, Yong Li, S. Southwood, A. Sette, S. Rosenberg, P. Robbins (1996)
Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopesThe Journal of Experimental Medicine, 183
Liangji Zhou, T. Tedder (1995)
Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.Journal of immunology, 154 8
W. Dummer, Jürgen Becker, A. Schwaaf, Martin Leverkus, T. Moll, E. Bröcker (1995)
Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma.Melanoma research, 5 1
B. Eynde, P. Bruggen (1997)
T cell defined tumor antigens.Current opinion in immunology, 9 5
(1999)
Full maturation of human monocyte derived dendritic cells results in stable expression of MHC class I molecules
F. Hsu, C. Benike, F. Fagnoni, T. Liles, D. Czerwinski, B. Taidi, E. Engleman, R. Levy (1996)
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cellsNature Medicine, 2
J. Banchereau, R. Steinman (1998)
Dendritic cells and the control of immunityNature, 392
Wolfgang Herr, Bruno Linn, Nicole Leister, Eveline Wandel, Karl‐Hermann Büschenfelde, T. Wölfel (1997)
The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens.Journal of immunological methods, 203 2
P. Romero, J. Cerottini, G. Waanders (1998)
Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy.Molecular medicine today, 4 7
H. Jonuleit, U. Kühn, G. Müller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop, A. Enk (1997)
Pro‐inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum‐free conditionsEuropean Journal of Immunology, 27
M. Dhodapkar, R. Steinman, M. Sapp, H. Desai, Coraleen Fossella, J. Krasovsky, S. Donahoe, P. Dunbar, V. Cerundolo, D. Nixon, N. Bhardwaj (1999)
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.The Journal of clinical investigation, 104 2
A. Lanzavecchia (1998)
Licence to killNature, 393
B. Gaugler, B. Eynde, P. Bruggen, P. Romero, J. Gaforio, E. Plaen, Bernard Letht, F. Brasseur, T. Boon (1994)
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytesThe Journal of Experimental Medicine, 179
(1999)
Dendritic cell therapy of cancer and HIV infection
J. Sarmiento, T. Hughes, R. Stouffer, S. Manabe (1998)
Simulated response of the ocean carbon cycle to anthropogenic climate warmingNature, 393
M. Cella, A. Engering, V. Pinet, J. Pieters, A. Lanzavecchia (1997)
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cellsNature, 388
Takami Sato, P. Mccue, K. Masuoka, S. Salwen, E. Lattime, M. Mastrangelo, D. Berd (1996)
Interleukin 10 production by human melanoma.Clinical cancer research : an official journal of the American Association for Cancer Research, 2 8
P. Chaux, V. Vantomme, P. Coulie, T. Boon, P. Bruggen (1998)
Estimation of the frequencies of anti‐MAGE‐3 cytolytic T‐lymphocyte precursors in blood from individuals without cancerInternational Journal of Cancer, 77
M. Dieu, B. Vanbervliet, A. Vicari, J. Bridon, E. Oldham, S. Aït-Yahia, F. Brière, A. Zlotnik, S. Lebecque, C. Caux (1998)
Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic SitesThe Journal of Experimental Medicine, 188
D. Lowy, Ian Frazer (1998)
Cancer vaccinesInpharma Weekly, 1130
P. Chaux, V. Vantomme, V. Stroobant, K. Thielemans, J. Corthals, R. Luiten, A. Eggermont, T. Boon, P. Bruggen (1999)
Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T LymphocytesThe Journal of Experimental Medicine, 189
The Journal of Experimental Medicine – Unpaywall
Published: Dec 6, 1999
Access the full text.
Sign up today, get DeepDyve free for 14 days.